WYNYARD, UK, Jan. 4, 2021 /PRNewswire/ -- Venator
Materials PLC (NYSE: VNTR) ("Venator") announced today that
Barry B. Siadat, Aaron C. Davenport and Heike van de Kerkhof have been elected as new
members to its Board of Directors.
The appointment of Dr. Siadat was effective December 31, 2020. Prior to co-founding SK
Capital Partners, Dr. Siadat worked for 37 years in the chemicals
and materials industries as an inventor, operator and investor. Dr.
Siadat has been the chairman of several specialty materials and
chemicals companies. He currently serves as Chairman of the Board
for Ascend Performance Materials, Aristech Acrylics, Archroma and
SI Group. Additionally, he serves on the Board of Directors of Mt.
Sinai Hospital in Miami Beach. Dr.
Siadat has been elected Chairman of the Board of Directors of
Venator.
The appointment of Mr. Davenport was effective January 1, 2021. Mr. Davenport also is a managing
director of SK Capital, focusing on the specialty chemicals and
pharmaceutical industries. He currently serves as Chairman of the
Board of Noramco, Tasmanian Alkaloids, Wavelength Pharmaceuticals
and Perimeter Solutions. Mr. Davenport was appointed to serve on
Venator's Nominating and Corporate Governance Committee.
The appointment of Ms. van de Kerkhof was effective January 1, 2021. Ms. van de Kerkhof has more than
30 years´ experience in the chemicals and materials
industries. She is currently Chief Executive Officer and a
member of the Board of Directors at Archroma Management GmbH. Prior
to Archroma, she held leadership positions across various functions
at DuPont from 1989 to 2015 and at Chemours, from 2015 – 2017. Ms.
van de Kerkhof was appointed to serve as Chair of Venator's
Nominating and Corporate Governance Committee and a member of its
Compensation Committee.
Daniele Ferrari, Peter R. Huntsman, Kathy
D. Patrick and Simon Turner
will continue to serve on the Board as a Directors. Mr. Ferrari was
appointed Chair of the Audit Committee and member of the
Compensation Committee and member of the Nominating and Corporate
Governance Committee. Mr. Huntsman was appointed to serve as member
of the Audit Committee. Ms. Patrick was appointed Chair of the
Compensation Committee and member of the Audit Committee.
Douglas D. Anderson and Sir
Robert J. Margetts have each
resigned from the Board, effective January
1, 2021.
Simon Turner, President and CEO
of Venator, commented, "We are pleased to welcome Barry, Aaron and
Heike to our Board of Directors. They each have a wealth of
experience within the chemical industry and are valuable additions
to the Board. I look forward to working with them on future
strategy and value creation opportunities for Venator."
About Venator
Venator is a global manufacturer and
marketer of chemical products that comprise a broad range of
pigments and additives that bring color and vibrancy to buildings,
protect and extend product life, and reduce energy consumption. We
market our products globally to a diversified group of industrial
customers through two segments: Titanium Dioxide, which consists of
our TiO2 business, and Performance Additives, which
consists of our functional additives, color pigments, timber
treatment and water treatment businesses. We operate 24 facilities,
employ approximately 4,000 associates worldwide and sell our
products in more than 110 countries.
Cautionary Statement Concerning Forward-Looking
Statements
Certain statements contained in this press
release constitute "forward looking statements" within the meaning
of the U.S. Private Securities Litigation Reform Act of 1995. These
forward looking statements represent Venator's expectations or
beliefs concerning future events, and it is possible that the
expected results described in this press release will not be
achieved. These forward looking statements are subject to risks,
uncertainties and other factors, many of which are outside of
Venator's control, that could cause actual results to differ
materially from the results discussed in the forward looking
statements, including the impacts and duration of the global
outbreak of the Coronavirus Disease 2019 pandemic on the global
economy and all aspects of our business, including our employees,
customers, suppliers, partners, results of operations, financial
condition and liquidity, global economic conditions, our ability to
maintain sufficient working capital, our ability to access capital
markets on favorable terms, our ability to transfer technology and
manufacturing capacity from our Pori, Finland manufacturing facility to other sites
in our manufacturing network, the costs associated with such
transfer and the closure of our Pori facility, our ability to
realize financial and operational benefits from our business
improvement plans and initiatives, impacts on TiO2
markets and the broader global economy from the imposition of
tariffs by the U.S. and other countries, changes in raw material
and energy prices, or interruptions in raw materials and energy,
industry production capacity and operating rates, the supply demand
balance for our products and that of competing products, pricing
pressures, technological developments, legal claims by or against
us, changes in government regulations, including increased
manufacturing, labeling and waste disposal regulations and the
classification of TiO2 as a carcinogen in the EU,
geopolitical events, cyberattacks and public health crises such as
coronavirus.
Any forward looking statement speaks only as of the date on
which it is made, and, except as required by law, Venator does not
undertake any obligation to update or revise any forward looking
statement, whether as a result of new information, future events or
otherwise. New factors emerge from time to time, and it is not
possible for Venator to predict all such factors. When considering
these forward looking statements, you should keep in mind the risk
factors and other cautionary statements in Venator's Annual Report
on Form 10-K for the year ended December 31,
2019 filed with the SEC and in its Quarterly Reports on Form
10-Q and Current Reports on Form 8-K. The risk factors and other
factors noted therein could cause its actual results to differ
materially from those contained in any forward looking
statement.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/venator-board-elects-three-new-directors-301200110.html
SOURCE Venator Materials PLC